Print this pageSponsorship
The Cancer Institute NSW will consider sponsorship requests that support key stakeholders involved in the delivery and implementation of the NSW Cancer Plan, and that promotes activities and events which fall within the strategic framework of the NSW Cancer Plan:
- Reduction in cancer incidence
- Increase cancer survival
- Improve the quality of life of cancer patients and their carers
- Provide expert advice to patients, the public, healthcare professionals and organisations engaged in cancer control.
Sponsorship will be considered for activities that promote the control and defeat of cancer. This may include events that increase the awareness of cancer, promote cancer-avoiding behaviours and foster the uptake of early detection programmes or promote optimal therapy.
The Cancer Institute will also consider sponsorship proposals, including conferences, seminars and other educational programmes, that disseminate knowledge to key stakeholders and extend best practice across the clinical and supportive care pathway for people affected by cancer.
Sponsorship proposals outlining how the event, its aim, audience, content and profile contributes to the above criteria and increases the profile of the Cancer Institute should be sent to the Chief Cancer Officer.
If you wish to submit a proposal for Cancer Institute NSW sponsorship, please click here.
Alternatively, you can download and
complete the Sponsorship Initiative Submission form 
and follow the instructions.
For further details, call the Manager, Cancer Communications on 02 8374 5600.
Current Events and Initiatives we are Supporting
The Australasian Gastro-Intestinal Trials Group (AGITG) meeting - Sofitel Wentworth, Sydney, 3-5 September 2008
The AGITG meeting promotes the control and defeat of cancer by promoting optimal cancer therapies to clinicians. It is the only professional meeting in the Australasian region that disseminates gastrointestinal cancer knowledge to key stakeholders.
The meeting is an important opportunity to gain new insights on gastro-intestinal cancer trials, research and treatments. Each year over 20,000 Australians and New Zealanders are diagnosed with GI cancers and more than half will die within five years of their diagnosis. In Australia alone more than 90 people die each week from GI Cancer.
3rd HMRI Conference in Translational Cancer Research - Newcastle City Hall - 10-12 Sept 2008
This 3rd Conference conducted by the Hunter Medical Research Institute brings together an outstanding group of national and international scientists andclinicians to share the latest advances in diagnostics, biochemistry, molecular biology, genetics, proteomics, biomarkers and stem cell function in relation to thedevelopment of tailored markers. The Cancer Institute's Sponsorship package will meet the costs for Dr Anil Potti from Duke University Medical Centre, Durham, USA to attend and speak.
18th St Vincents & Mater Health Sydney Research Symposium - Garvan Institute of Medical Research - NAB Auditorium - 19 September 2008
The Symposium is jointly held by the Garvan Institute, Victor Chang Institute, St Vincents Hospital Research, University of NSW, Centre for Immunology, the National Centre in HIV and Epidemiology and Clinical Research and researchers from other National Research organisations.
The Symposium attracts significant representation of the Australian research community. Cancer Institute NSW's Gold sponsorship of this event supports the "Cancer Institute NSW Award for Excellence in Oral Presentation".
Research Development Workshop in Palliative Care - Novotel, Coffs Harbour - 4 November 2008
The Workshop will cover aspects of research development and design in palliative care, as well as highlight skills and infrastructure requirements for effective and high quality research in this area. Palliative care research in NSW is minimal.
The Workshop is seeking to foster a critical mass of clinicians with research ability and training in the basic skills to commence research. Co-ordination of this crtical mass through the new Professor of Palliative medicine position at University of NSW and the Clinical Trials PC committee aims to achieve research that influences behaviours in health care and better outcomes for cancer patients.
Association of Genetic Support of Australasia Inc. (AGSA) - Annual Information Day - Citygate Sebel Hotel, Sydney - 12 October 2008
This Information Day provides up-to-date information to individuals at high risk of breast and/or ovarian cancer regarding early detection and cancer prevention strategies, assists decision-making and cancer-avoiding behaviours, promoting Cancer Institute NSW through Familial Cancer Services, local media, Cancer Council NSW and relevant cancer support services.
The Day will provide information on surveillance and preventative measures to reduce incidence of cancer in this group at high risk due to genetic predisposition.
"Success in Clinical Trials: the Way Forward" - Tasman Oncology Group (TROG) - Star Room, Darling Harbour - 12 November 2008
This workshop aims to build upon the success of the May 2007 workshop "Success in Clinical Trials: Key People & Processes" held to facilitate discussion and ideas about how to identify, develop and maintain the key processes required to achieve success in clinical trial participation in NSW.
The workshop emphasises how NSW can build on the roles and processes that are in development or have been developed to improve clinical trial participation - including involving a broader range of members from the multidisciplinary team in trial development, considering options for trials concepts involving technical developments in radiotherapy, and improved communication with the public and cancer patients about the positive role that clinical trials in NSW have in improving cancer management and care for the present and future.
COSA ASM 2008 - Sydney Convention Centre – 18-20 Nov
The Cancer Institute NSW is platinum sponsor of this year’s Annual Scientific Meeting of The Clinical Oncological Society of Australia in partnership with the International Association of Cancer Registries (IACR) & ANZ Gastro Oesophageal Surgery Association (ANZGOSA).
More than 1000 leading cancer specialists and health professionals from the Asia Pacific are expected to attend Information In-Information Out, a joint meeting with the IACR and ANZGOSA which with plenaries, symposia and group sessions promises to be Australia’s biggest ever cancer meeting.
For further information click here.
Study: Cognitive Rehabilitation for Cancer Survivors - commencing Jan 2009
The proposed cognitive rehabilitation programme has the potential to improve cognitive functioning, quality of life and affective symptoms of breast cancer survivors – leading to a better health outcome. At present there is no known treatment for cognitive impairment or self-reported impairment, post cancer-treatment
Cancer survivors have a strong interest in the issue of cognitive function after cancer treatment. This study has the potential to change standard practice and can be incorporated into survivorship programmes.
